Quantitation of chemosensitivity in acute myelocytic leukaemia.
A system for the prediction of clinical response in acute myelocytic leukaemia (AML), based on inhibition of growth of colony forming cells (CFC) was studied. If the product of initial drug concentration and time of exposure (C X T) was constant, the response to adriamycin (Adr) was constant, at T v...
Main Authors: | Lihou, M. G., Smith, P. J. |
---|---|
Format: | Online |
Language: | English |
Published: |
1983
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011489/ |
Similar Items
-
A Case of Myelocytic Leukæmia with Complications
by: McCay, F., et al.
Published: (1935) -
Induction of the pro-myelocytic leukaemia gene by type I and type II interferons.
by: Heuser, M, et al.
Published: (1998) -
In vitro testing of chemotherapeutic drug combinations in acute myelocytic leukaemia using the fluorometric microculture cytotoxicity assay (FMCA).
by: Larsson, R., et al.
Published: (1993) -
Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia.
by: Sargent, J. M., et al.
Published: (1989) -
Multidrug resistance phenotype in leukaemic cells from patients with acute myelocytic leukaemia can be detected with 99Tc(m)-MIBI.
by: Gruber, A., et al.
Published: (1998)